Guidelines for treatment of onychomycosis

Br J Dermatol. 2003 Mar;148(3):402-10. doi: 10.1046/j.1365-2133.2003.05242.x.

Abstract

These guidelines for management of onychomycosis have been prepared for dermatologists on behalf of the British Association of Dermatologists. They present evidence-based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines, and a brief overview of epidemiological aspects, diagnosis and investigation.

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • Administration, Topical
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / therapeutic use*
  • Candidiasis / diagnosis
  • Candidiasis / drug therapy
  • Dermatomycoses / diagnosis
  • Dermatomycoses / drug therapy
  • Griseofulvin / therapeutic use
  • Humans
  • Itraconazole / therapeutic use
  • Naphthalenes / therapeutic use
  • Onychomycosis / diagnosis
  • Onychomycosis / drug therapy*
  • Terbinafine
  • Treatment Failure

Substances

  • Antifungal Agents
  • Naphthalenes
  • Itraconazole
  • Griseofulvin
  • Terbinafine